Related Experiment Video
Updated: Aug 16, 2026
09:30
Precision Induction and Distinction of Coughing and Sneezing Reflexes in Mice
Published on: October 3, 2025
New Products
Science (New York, N.Y.)
|August 14, 2026
Summary
Researchers can discover new laboratory instrumentation, apparatus, and materials weekly. This roundup highlights the latest offerings to advance scientific research and development.
Area of Science:
- Laboratory Science
- Research and Development
- Scientific Instrumentation
Background:
- The rapid advancement of scientific research necessitates continuous access to cutting-edge laboratory tools.
- Researchers require timely information on new instrumentation and materials to maintain a competitive edge.
Purpose of the Study:
- To provide a curated, weekly summary of novel laboratory instrumentation, apparatus, and materials.
- To inform researchers about the latest technological developments relevant to their work.
Main Methods:
- Compilation of information from various sources on newly available laboratory products.
- Categorization and presentation of offerings for easy researcher review.
Main Results:
- A consistent weekly stream of information on new laboratory supplies.
- Identification of emerging trends in laboratory equipment and materials.
Conclusions:
- Regular updates on new laboratory offerings can significantly aid researchers in selecting appropriate tools.
- Staying informed about the latest instrumentation is crucial for scientific progress and innovation.
Related Concept Videos
01:26FDA Approved Drugs: Changes to Approved Drugs
Post-approval, manufacturers may modify an approved new or generic drug product. Such modifications can encompass alterations in the Active Pharmaceutical Ingredient (API), manufacturing process, formulation, batch size, manufacturing site, and container closure system (FDA Guidance for Industry, April 2004). Often, a drug product may undergo multiple changes.These modifications require careful evaluation to determine their potential impact on the drug product's identity, strength, quality,...
02:27Predicting Products: SN1 vs. SN2
Nucleophilic substitution reactions of alkyl halides can proceed via an SN1 or an SN2 mechanism. While in SN2 reactions, the nucleophile attacks the substrate simultaneously as the leaving group departs, in SN1 reactions, the substrate first dissociates to give the carbocation intermediate. Various factors such as the structure of the substrate, the strength of the nucleophile, and the nature of the solvent promote one mechanism over the other.
With increased substitution on the alkyl halide,...
With increased substitution on the alkyl halide,...
02:52Predicting Products: Substitution vs. Elimination
When a nucleophile and an alkyl halide react, nucleophilic substitution and β-elimination reactions compete to generate products.
The following factors can influence the mechanisms competing against each other:
The following factors can influence the mechanisms competing against each other:
01:28Drug Products: Biologics, Biosimilars and Interchangeables
Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
01:29Clinically Relevant Drug Product Specifications: Methods of Establishment
Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
01:26Pharmaceutical Equivalents
As defined by regulatory standards, pharmaceutical equivalents require generic drug products to have identical dosage forms and chemically identical active pharmaceutical ingredients (APIs). They must adhere to compendial or applicable standards for potency, content uniformity, disintegration times, and dissolution rates. In the case of modified-release dosage forms, variations in drug content are permissible as long as the delivered amount remains consistent with the innovator drug product.